Company / Gross Profit per Share
AYTU BIOPHARMA, INC Gross Profit per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$7.67
FY2025
5-year range
$1.90 / $34.54
FY2021-FY2025
Trend
-13.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 6 years, ranging from $1.10 in FY2020 to $34.54 in FY2023.
Based on SEC 10-K filings.
7.67 in FY2025 with a 5-year CAGR of +47.4%.
Declined from $34.54 to $7.67 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +59.2%
- 5-Year CAGR
- +47.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share decreased 13.7% year-over-year.
- Peak gross profit per share was recorded in FY2023.
- Lowest gross profit per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.67 | -13.7% |
| FY2024 | $8.89 | -74.3% |
| FY2023 | $34.54 | +1716.3% |
| FY2022 | $1.90 | -18.0% |
| FY2021 | $2.32 | +110.3% |
| FY2020 | $1.10 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026